| Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation D De Groote, PF Zangerle, Y Gevaert, MF Fassotte, Y Beguin, ... Cytokine 4 (3), 239-248, 1992 | 616 | 1992 |
| Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management K Yazdanbakhsh, RE Ware, F Noizat-Pirenne Blood, The Journal of the American Society of Hematology 120 (3), 528-537, 2012 | 446 | 2012 |
| American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support ST Chou, M Alsawas, RM Fasano, JJ Field, JE Hendrickson, J Howard, ... Blood advances 4 (2), 327-355, 2020 | 315 | 2020 |
| Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19 T Hueso, C Pouderoux, H Péré, AL Beaumont, LA Raillon, F Ader, ... Blood, The Journal of the American Society of Hematology 136 (20), 2290-2295, 2020 | 288 | 2020 |
| Maturation and persistence of the anti-SARS-CoV-2 memory B cell response A Sokal, P Chappert, G Barba-Spaeth, A Roeser, S Fourati, I Azzaoui, ... Cell 184 (5), 1201-1213. e14, 2021 | 286 | 2021 |
| Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety F Noizat-Pirenne, K Lee, PYL Pennec, P Simon, P Kazup, D Bachir, ... Blood, The Journal of the American Society of Hematology 100 (12), 4223-4231, 2002 | 181 | 2002 |
| Characteristics and outcome of warm autoimmune hemolytic anemia in adults: new insights based on a single‐center experience with 60 patients M Roumier, V Loustau, C Guillaud, L Languille, M Mahevas, M Khellaf, ... American journal of hematology 89 (9), E150-E155, 2014 | 174 | 2014 |
| ABO blood group and COVID‐19: a review on behalf of the ISBT COVID‐19 working group R Goel, EM Bloch, F Pirenne, AZ Al‐Riyami, E Crowe, L Dau, K Land, ... Vox sanguinis 116 (8), 849-861, 2021 | 161 | 2021 |
| How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions F Pirenne, K Yazdanbakhsh Blood, The Journal of the American Society of Hematology 131 (25), 2773-2781, 2018 | 150 | 2018 |
| Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis F Noizat‐Pirenne, C Tournamille, P Bierling, F Roudot‐Thoraval, ... Transfusion 46 (8), 1328-1333, 2006 | 139 | 2006 |
| Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death P Chadebech, A Habibi, R Nzouakou, D Bachir, N Meunier‐Costes, ... Transfusion 49 (9), 1785-1792, 2009 | 126 | 2009 |
| Delayed hemolytic transfusion reaction in adult sickle‐cell disease: presentations, outcomes, and treatments of 99 referral center episodes A Habibi, A Mekontso‐Dessap, C Guillaud, M Michel, K Razazi, M Khellaf, ... American Journal of Hematology 91 (10), 989-994, 2016 | 122 | 2016 |
| Delayed hemolytic transfusion reaction in children with sickle cell disease M De Montalembert, MD Dumont, C Heilbronner, V Brousse, O Charrara, ... haematologica 96 (6), 801, 2011 | 116 | 2011 |
| Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease D Narbey, A Habibi, P Chadebech, A Mekontso‐Dessap, M Khellaf, ... American journal of hematology 92 (12), 1340-1348, 2017 | 111 | 2017 |
| mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants A Sokal, G Barba-Spaeth, I Fernández, M Broketa, I Azzaoui, ... Immunity 54 (12), 2893-2907. e5, 2021 | 101 | 2021 |
| Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients G Dumas, A Habibi, T Onimus, JC Merle, K Razazi, A Mekontso Dessap, ... Blood, The Journal of the American Society of Hematology 127 (8), 1062-1064, 2016 | 95 | 2016 |
| Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease F Noizat-Pirenne, D Bachir, P Chadebech, M Michel, A Plonquet, ... Haematologica 92 (12), e132-e135, 2007 | 93 | 2007 |
| RhD variants in Caucasians: consequences for checking clinically relevant alleles H Ansart‐Pirenne, M Asso‐Bonnet, PYL Pennec, M Roussel, C Patereau, ... Transfusion 44 (9), 1282-1286, 2004 | 87 | 2004 |
| Control of humoral response in renal transplantation by belatacept depends on a direct effect on B cells and impaired T follicular helper-B cell crosstalk C Leibler, A Thiolat, C Hénique, C Samson, C Pilon, M Tamagne, ... Journal of the American Society of Nephrology 29 (3), 1049-1062, 2018 | 84 | 2018 |
| Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization C Tournamille, N Meunier‐Costes, B Costes, J Martret, A Barrault, ... Transfusion 50 (1), 13-19, 2010 | 82 | 2010 |
